Pebblebrook Hotel Trust (PEB)

Revance Therapeutics Statistics

Total Valuation

PEB has a market cap or net worth of $1.18 billion. The enterprise value is $3.53 billion.

Market Cap	1.18B
Enterprise Value	3.53B

Important Dates

The last earnings date was Tuesday, July 29, 2025, after market close.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Jun 30, 2025

Share Statistics

PEB has 119.75 million shares outstanding. The number of shares has decreased by -0.83% in one year.

Current Share Class	118.57M
Shares Outstanding	119.75M
Shares Change (YoY)	-0.83%
Shares Change (QoQ)	-0.69%
Owned by Insiders (%)	2.31%
Owned by Institutions (%)	118.84%
Float	115.78M

Valuation Ratios

Price/FFO Ratio	n/a
Price/AFFO Ratio	n/a
PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.80
Forward PS	0.78
PB Ratio	0.44
P/TBV Ratio	0.45
P/FCF Ratio	n/a
P/OCF Ratio	4.13
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.40
EV / EBITDA	11.65
EV / EBIT	48.32
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.96.

Current Ratio	1.78
Quick Ratio	1.38
Debt / Equity	0.96
Debt / EBITDA	7.62
Debt / FCF	n/a
Interest Coverage	0.65

Financial Efficiency

Return on equity (ROE) is -0.63% and return on invested capital (ROIC) is 0.85%.

Return on Equity (ROE)	-0.63%
Return on Assets (ROA)	0.80%
Return on Invested Capital (ROIC)	0.85%
Return on Capital Employed (ROCE)	1.35%
Revenue Per Employee	$24.50M
Profits Per Employee	-$1.07M
Employee Count	60
Asset Turnover	0.26
Inventory Turnover	n/a

Taxes

Income Tax	-22.03M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.50% in the last 52 weeks. The beta is 1.86, so PEB's price volatility has been higher than the market average.

Beta (5Y)	1.86
52-Week Price Change	-16.50%
50-Day Moving Average	9.97
200-Day Moving Average	11.36
Relative Strength Index (RSI)	42.23
Average Volume (20 Days)	2,278,461

Short Selling Information

The latest short interest is 11.18 million, so 9.34% of the outstanding shares have been sold short.

Short Interest	11.18M
Short Previous Month	10.67M
Short % of Shares Out	9.34%
Short % of Float	9.66%
Short Ratio (days to cover)	4.95

Income Statement

In the last 12 months, PEB had revenue of $1.47 billion and -$64.28 million in losses. Loss per share was -$0.54.

Revenue	1.47B
Gross Profit	355.62M
Operating Income	73.09M
Pretax Income	-82.74M
Net Income	-64.28M
EBITDA	303.31M
EBIT	73.09M
Loss Per Share	-$0.54

Balance Sheet

The company has $263.53 million in cash and $2.61 billion in debt, giving a net cash position of -$2.35 billion or -$19.63 per share.

Cash & Cash Equivalents	263.53M
Total Debt	2.61B
Net Cash	-2.35B
Net Cash Per Share	-$19.63
Equity (Book Value)	2.73B
Book Value Per Share	22.33
Working Capital	176.73M

Cash Flow

Operating Cash Flow	286.21M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 24.19%, with operating and profit margins of 4.97% and -1.48%.

Gross Margin	24.19%
Operating Margin	4.97%
Pretax Margin	-2.70%
Profit Margin	-1.48%
EBITDA Margin	20.63%
EBIT Margin	4.97%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of $0.04, which amounts to a dividend yield of 0.41%.

Dividend Per Share	$0.04
Dividend Yield	0.41%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.83%
Shareholder Yield	1.23%
Earnings Yield	-5.44%
FCF Yield	n/a

Analyst Forecast

The average price target for PEB is $11.83, which is 19.86% higher than the current price. The consensus rating is "Hold".

Price Target	$11.83
Price Target Difference	19.86%
Analyst Consensus	Hold
Analyst Count	7
Revenue Growth Forecast (5Y)	3.39%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5